GLP-1 meds like Ozempic, Wegovy may lower cancer risk
Summary: A study suggests GLP-1 medications like Ozempic and Wegovy may lower the risk of certain cancers. Overweight individuals face a higher risk of 13 types of cancer, with 40% of new diagnoses linked to excess weight. GLP-1 treatment reduced the risk of 10 obesity-associated cancers, including gallbladder, pancreatic, and liver cancer. The study analyzed data from 1.7 million people with type 2 diabetes. Further research is needed on the relationship between weight loss and cancer risk reduction.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings